Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now small index

Lifestyle clinical trials

3 of 7 indexed Lifestyle trials are currently recruiting.

Corpus placement: #2,497 of 28,707 conditions by registered trial count.

7 US clinical trials · 3 currently recruiting · #2,497 of 28,707 conditions by registered trial count

Lifestyle: 7 US clinical trials tracked, 3 recruiting.

Lifestyle is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. The most active sponsor is Imad Najm MD, running 1 of these trials.

Enrollment posture brief

Registry condition lifestyle

OPEN 3 | RECR 43% | LATE 0 | EARLY 0 | RANK #2497 | SPON 1

Nearest open-share peer: Adrenoleukodystrophy (43% recruiting · 7 trials)

ACL Tear71.4%ACL57.1%Lifestyle (this)43%Acute Myelogenous Leukemia42.9%Acne Scars28.6%
Open-enrollment share among volume-matched conditions near Lifestyle

Lifestyle lists 3 open slots (43% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Lifestyle on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Lifestyle is recruiting below its size-band peers.

    3 of 7 indexed trials (42.9%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Lifestyle trials is spread across many organizations.

    Imad Najm MD accounts for 1 of 7 trials (14.3%). 7 distinct sponsors appear on at least one study for this condition label.

  3. Typical Lifestyle enrolment sits around 135 participants.

    Median target enrolment is 135 among the 7 trials that report a genuine target (sentinel values excluded). 3 of those (42.9%) plan for fewer than 100 participants.

  4. Lifestyle research is mostly interventional.

    7 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase Distribution

Phase data not available

Named interventions

Most-linked intervention names on Lifestyle records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

ACT-PA Behavioral
1 trials
PhytoGanix (tropical fruit flavor) Other
1 trials
Stress Management Recommendations Other
1 trials
Exercise Recommendations Other
1 trials
Lifestyle Recommendations Other
1 trials
Diet Recommendations Other
1 trials
Couple-based intervention condition (PreventT2 Together; couple-based adaptation of 2021 PreventT2; approved by the CDC in November 2022 as an Alternate Curriculum for use in the NDPP) Behavioral
1 trials
Individual intervention condition (PreventT2) Behavioral
1 trials

US sites by state

Facility locations filed on Lifestyle trials. A trial with sites in several states counts in each.

Utah 1 trials
Texas 1 trials
Rhode Island 1 trials
Oregon 1 trials
Ohio 1 trials
Massachusetts 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Lifestyle page

7 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Lifestyle condition card totals 7 registered trials; most-linked intervention ACT-PA; top US site state Utah. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.